Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas E. Robinson has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Simultaneous viscoelasticity and sprayability in antimicrobial acetic acid-alginate fluid gels

    by Thomas E. Robinson, Callum Clark, Richard J.A. Moakes, Zoe Schofield, Naiem Moiemen, Joan A. Geoghegan, Liam M. Grover


  • Open Access

    Self‐Delivering Microstructured Iota Carrageenan Spray Inhibits Fibrosis at Multiple Length Scales

    by Thomas E. Robinson, Mathieu Y. Brunet, Iain Chapple, Adrian H. M. Heagerty, Anthony D. Metcalfe, Liam M. Grover

    Fibrotic diseases account for 45% of all deaths in the developed world, and progressive scarring conditions, such as dystrophic epidermolysis bullosa (EB), result in a significant reduction in quality of life. There is thus a need for novel approaches in fibrosis prevention. Herein, it is shown that iota carrageenan, a low‐cost, regulatory approved polysaccharide, is effective at preventing scarring by inhibiting collagen fibrillogenesis, abrogating the transforming growth factor beta 1 (TGFβ1) pathway, and lubricating the epithelium. It is demonstrated that iota carrageenan, and other anionic polysaccharides, can prevent collagen fibril formation, a key step in scar formation. It also binds TGFβ1 to prevent myofibroblast transdifferentiation, evidenced by a significant reduction in both transcription and translation of collagen 1 and alpha smooth muscle actin. Iota carrageenan may be formulated as a microparticle suspension, to allow spraying for even coverage on hard‐to‐reach anatomical sites, like the oral mucosa. This formulation provides good lubrication, to reduce the shear forces that initiate the progressive oral scarring in EB. This study not only provides a novel therapy for fibrosis prevention, but also demonstrates the potential of self‐delivering immunomodulatory polysaccharides as a safe, cost‐effective, and stable platform, which can be more easily translated for clinical benefit.


  • Open Access

    Can We Structure Biomaterials to Spray Well Whilst Maintaining Functionality?

    by Richard J. A. Moakes, Liam M. Grover, Thomas E. Robinson

    Structured fluid biomaterials, including gels, creams, emulsions and particle suspensions, are used extensively across many industries, including great interest within the medical field as controlled release vehicles to improve the therapeutic benefit of delivered drugs and cells. Colloidal forces within these materials create multiscale cohesive interactions, giving rise to intricate microstructures and physical properties, exemplified by increasingly complex mathematical descriptions. Yield stresses and viscoelasticity, typically arising through the material microstructure, vastly improve site-specific retention, and protect valuable therapeutics during application. One powerful application route is spraying, a convenient delivery method capable of applying a thin layer of material over geometrically uneven surfaces and hard-to-reach anatomical locations. The process of spraying is inherently disruptive, breaking a bulk fluid in successive steps into smaller elements, applying multiple forces over several length scales. Historically, spray research has focused on simple, inviscid solutions and dispersions, far from the complex microstructures and highly viscoelastic properties of concentrated colloidal biomaterials. The cohesive forces in colloidal biomaterials appear to conflict with the disruptive forces that occur during spraying. This review explores the physical bass and mathematical models of both the multifarious material properties engineered into structured fluid biomaterials and the disruptive forces imparted during the spray process, in order to elucidate the challenges and identify opportunities for rational design of sprayable, structured fluid biomaterials.


  • Portraying Older People in Advertising

    by Thomas E. Robinson

    First published in 1998. As society grows and changes, advertisers are faced with the challenge of matching their advertising messages to new and different target audiences. For example, children, adolescents, men, women, and "older" individuals are all audiences with specific needs, wants, and desires that advertisers must address in their advertising appeals. The purpose of this research is to determine the degree to which certain advertisements in the general interest media portray older individuals differently depending on the target audience. Specifically, this study examines advertisers’ attempts, in the electronic and print media, to target and attract the business of the older population.

  • Open Access

    Determining the Structure of Hexametaphosphate by Titration and 31P-NMR Spectroscopy

    by Thomas E. Robinson, Lucy A. Arkinstall, Sophie C. Cox, Liam M Grover

    Hexametaphosphate (HMP) is an inorganic condensed phosphate, which has been used in a wide variety of industries for nearly a century, originally patented to deflocculate clay and soften hard water...


  • Formulation of inherently antimicrobial magnesium oxychloride cement and the effect of supplementation with silver phosphate

    by Morgan Lowther, Thomas E. Robinson, Victor M. Villapun, Christopher P. Stark, Liam M. Grover, Sophie C. Cox


  • Open Access

    Local injection of a hexametaphosphate formulation reduces heterotopic ossification in vivo

    by T.E. Robinson, N.M. Eisenstein, S.C. Cox, R.J.A. Moakes, A.M. Thompson, Z. Ahmed, E.A.B. Hughes, L.J. Hill, S.A. Stapley, L.M. Grover


  • Open Access

    Hexametaphosphate as a potential therapy for the dissolution and prevention of kidney stones

    by Thomas E. Robinson, Erik A. B. Hughes, Oliver J. Wiseman, Sarah A. Stapley, Sophie C. Cox, Liam M. Grover

    Hexametaphosphate prevents aggregation and dissolves kidney stones an order of magnitude more effectively than the current therapy, citrate.


  • Open Access

    The Quantification of Injectability by Mechanical Testing

    by Thomas E. Robinson, Erik A. B. Hughes, Neil M. Eisenstein, Liam M. Grover, Sophie C. Cox

    Injectable biomaterials are becoming increasingly popular for the minimally invasive delivery of drugs and cells. These materials are typically more viscous than traditional aqueous injections and may be semi-solid, therefore, their injectability cannot be assumed. This protocol describes a method to objectively assess the injectability of these materials using a standard mechanical tester. The syringe plunger is compressed by the crosshead at a set rate, and the force is measured. The maximum or plateau force value can then be used for comparison between samples, or to an absolute force limit. This protocol can be used with any material, and any syringe and needle size or geometry. The results obtained may be used to make decisions about formulations, syringe and needle sizes early in the translational process. Further, the effects of altering formulations on injectability may be quantified, and the optimum time to inject temporally changing materials determined. This method is also suitable as a reproducible way to examine the effects of injection on a material, to study phenomena such as self-healing and filter pressing or study the effects of injection on cells. This protocol is faster and more directly applicable to injectability than rotational rheology, and requires minimal post processing to obtain key values for direct comparisons.


  • Open Access

    Filling the Gap: A Correlation between Objective and Subjective Measures of Injectability

    by Thomas E. Robinson, Erik A. B. Hughes, Aniruddha Bose, Elizabeth A. Cornish, Jun Y. Teo, Neil M. Eisenstein, Liam M. Grover, Sophie C. Cox

    Various injectable biomaterials are developed for the minimally invasive delivery of therapeutics. Typically, a mechanical tester is used to ascertain the force required to inject these biomaterials through a given syringe‐needle system. However, currently there is no method to correlate the force measured in the laboratory to the perceived effort required to perform that injection by the end user. In this article, the injection force (F) for a variety of biomaterials, displaying a range of rheological properties, is compared with the effort scores from a 50 person panel study. The maximum injection force measured at crosshead speed 1 mm s−1 is a good proxy for injection effort, with an R2 of 0.89. This correlation leads to the following conclusions: participants can easily inject 5 mL of substance for F < 12 N; considerable effort is required to inject 5 mL for 12 N < F < 38 N; great effort is required and F < 64 N; and materials are entirely non‐injectable for F > 64 N. These values may be used by developers of injectable biomaterials to make decisions about formulations and needle sizes early in the translational process.